Published in Medical Letter on the CDC and FDA, September 20th, 2009
Chairman and CEO Tom Wiggans described the year as one of tremendous progress for Peplin.
"Peplin's achievements this year of advancing PEP005 Gel through the completion of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA